The Asia Pacific Medical Aesthetics Market would witness market growth of 11.4% CAGR during the forecast period (2023-2030).
Government assistance, evolving beauty standards, and regional expertise all further the market's expansion. Key strategies include collaboration and diverse services tailored to local preferences. However, companies must navigate regulatory complexities, cultural differences, and economic fluctuations to flourish in these lucrative markets.
There has been a steady rise in aesthetic operations performed in recent years. Most of the population opts for minimally invasive and non-invasive procedures, such as botulinum toxin injections and dermal fillers, because of the numerous benefits associated with these procedures. The benefits are fewer adverse effects, a shorter recovery, and painless procedures.
According to the Invest India, in FY17, the hospital industry in India was worth $ 61.79 billion, and it is projected to reach $ 132 billion by 2023. Medical aesthetics clinics in India provide a broad spectrum of services, including non-surgical and minimally invasive treatments, facial rejuvenation, body contouring, hair restoration, and skin treatments. Healthcare providers in Indian medical aesthetics clinics assess each patient's unique needs and goals to create personalized treatment plans. This ensures that the patient's specific concerns are addressed. All these factors will uplift the expansion of the Asia Pacific market in coming years.
The China market dominated the Asia Pacific Medical Aesthetics Market by Country in 2022; and would continue to be a dominant market till 2030, thereby, achieving a market value of $2,389.5 million by 2030. The Japan market is registering a CAGR of 10.7% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 12.1% during (2023 - 2030).
Based on End User, the market is segmented into Clinics, Hospitals, & Medicals Spas, Beauty Centres, & Home Care Settings. Based on Procedure, the market is segmented into Non-Surgical Procedures (Anti-Aging And Skin Rejuvenation, Tattoo & Scar Removal, Hair Removal, Lipolysis, Others), & Surgical Procedures (Breast Augmentation, Facelift & Body Lift, Rhinoplasty, Others). Based on Product, the market is segmented into Facial Aesthetic Products, Body Contouring Devices, Hair Removal Devices, Physician-dispensed cosmeceuticals And Skin Lighteners, Cosmetics Implant, Skin Aesthetic Devices, Tattoo Removal Devices, & Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC (AbbVie, Inc.), Alma Lasers Ltd. (Sisram Medical Ltd.), Bausch Health Companies Inc, Anika Therapeutics, Inc, Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Candela corporation, Lumenis Be Ltd., Galderma S.A., and Cutera, Inc.
Government assistance, evolving beauty standards, and regional expertise all further the market's expansion. Key strategies include collaboration and diverse services tailored to local preferences. However, companies must navigate regulatory complexities, cultural differences, and economic fluctuations to flourish in these lucrative markets.
There has been a steady rise in aesthetic operations performed in recent years. Most of the population opts for minimally invasive and non-invasive procedures, such as botulinum toxin injections and dermal fillers, because of the numerous benefits associated with these procedures. The benefits are fewer adverse effects, a shorter recovery, and painless procedures.
According to the Invest India, in FY17, the hospital industry in India was worth $ 61.79 billion, and it is projected to reach $ 132 billion by 2023. Medical aesthetics clinics in India provide a broad spectrum of services, including non-surgical and minimally invasive treatments, facial rejuvenation, body contouring, hair restoration, and skin treatments. Healthcare providers in Indian medical aesthetics clinics assess each patient's unique needs and goals to create personalized treatment plans. This ensures that the patient's specific concerns are addressed. All these factors will uplift the expansion of the Asia Pacific market in coming years.
The China market dominated the Asia Pacific Medical Aesthetics Market by Country in 2022; and would continue to be a dominant market till 2030, thereby, achieving a market value of $2,389.5 million by 2030. The Japan market is registering a CAGR of 10.7% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 12.1% during (2023 - 2030).
Based on End User, the market is segmented into Clinics, Hospitals, & Medicals Spas, Beauty Centres, & Home Care Settings. Based on Procedure, the market is segmented into Non-Surgical Procedures (Anti-Aging And Skin Rejuvenation, Tattoo & Scar Removal, Hair Removal, Lipolysis, Others), & Surgical Procedures (Breast Augmentation, Facelift & Body Lift, Rhinoplasty, Others). Based on Product, the market is segmented into Facial Aesthetic Products, Body Contouring Devices, Hair Removal Devices, Physician-dispensed cosmeceuticals And Skin Lighteners, Cosmetics Implant, Skin Aesthetic Devices, Tattoo Removal Devices, & Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC (AbbVie, Inc.), Alma Lasers Ltd. (Sisram Medical Ltd.), Bausch Health Companies Inc, Anika Therapeutics, Inc, Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Candela corporation, Lumenis Be Ltd., Galderma S.A., and Cutera, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User- Clinics, Hospitals, & Medicals Spas
- Beauty Centers
- Home Care Settings
- Non-Surgical Procedures
- Anti-Aging And Skin Rejuvenation
- Tattoo & Scar Removal
- Hair Removal
- Lipolysis
- Others
- Surgical Procedures
- Breast Augmentation
- Facelift & Body Lift
- Rhinoplasty
- Others
- Facial Aesthetic Products
- Body Contouring Devices
- Hair Removal Devices
- Physician-dispensed cosmeceuticals And Skin Lighteners
- Cosmetics Implant
- Skin Aesthetic Devices
- Tattoo Removal Devices
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Allergan PLC (AbbVie, Inc.)
- Alma Lasers Ltd. (Sisram Medical Ltd.)
- Bausch Health Companies Inc
- Anika Therapeutics, Inc
- Johnson & Johnson
- Merz Pharma GmbH & Co. KGaA
- Candela corporation
- Lumenis Be Ltd.
- Galderma S.A.
- Cutera, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Asia Pacific Medical Aesthetics Market by End User
Chapter 6. Asia Pacific Medical Aesthetics Market by Procedure
Chapter 7. Asia Pacific Medical Aesthetics Market by Product
Chapter 8. Asia Pacific Medical Aesthetics Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Allergan PLC (AbbVie, Inc.)
- Alma Lasers Ltd. (Sisram Medical Ltd.)
- Bausch Health Companies Inc
- Anika Therapeutics, Inc
- Johnson & Johnson
- Merz Pharma GmbH & Co. KGaA
- Candela corporation
- Lumenis Be Ltd.
- Galderma S.A.
- Cutera, Inc.
Methodology
LOADING...
